FDA Approves Biogen’s Lecanemab

 Neuroscience pioneer, Biogen, Inc. (Nasdaq: BIIB) has received FDA approval for lecanemab for the treatment of Alzheimer’s disease (AD). The FDA’s accelerated approval is based… [Read More]

Lexaria Oral Nicotine Study Begins Dosing

Lexaria Bioscience, (Nasdaq: LEXX) has begun dosing subjects in an oral nicotine study that will compare DehydraTECH-nicotine pouch performance to existing leading brands ON!, manufactured… [Read More]